the trials have sought to establish that aspirin ( asa ) , sulphinpyrazone and dipyridamole may prevent thrombosis in the form of recurrence of transient ischaemic attack ( tia ) and stroke or reduce the recurrence rate and mortality after acute myocardial infarction .
C0038742
sulphinpyrazone
C0040053
thrombosis